Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Squamous Cell Carcinoma: A Cohort Study

NCT06929468 is registered in ClinicalTrials.gov with Simon Jäger as lead sponsor.

NCT NCT06929468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06929468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Squamous Cell Carcinoma: A Cohort Study
Lead sponsor
Simon Jäger
Phase
Observational
Overall status
Not yet recruiting
Start date
July 31, 2025
Completion date
June 30, 2027
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cisplatin ototoxicity, cisplatin-induced hearing loss, deafness, dizzyness, head and neck cancer, hearing loss, inner ear hearing loss, ototoxic hearing loss, ototoxicity, drug-induced, squamous cell carcinoma of the head and neck, vestibular disease